ProQR Therapeutics NV (NASDAQ:PRQR)
| 2.16 Delayed Data As of Mar 31 |  +0.17 / +8.54%Today’s Change | 0.53 Today|||52-Week Range 3.85 | -41.62% Year-to-Date |
Latest PRQR News | Press Releases
| Why Shares of ProQR Therapeutics Dropped on Wednesday Mar 29 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.99 |
| Today’s open | 1.95 |
| Day’s range | 1.92 - 2.22 |
| Volume | 64,026 |
| Average volume (3 months) | 2,411,034 |
| Market cap | $170.5M |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +15.83% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +165.11% |
| P/E ratio | NM |
| Price/Sales | 62.48 |
| Price/Book | 2.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTXRCitius Pharmaceutica... | -0.01 | -0.85% |
| FULCFulcrum Therapeutics... | +0.01 | +0.36% |
| AADIAadi Bioscience Inc | +0.12 | +1.69% |
| DMTRF3-D Matrix Ltd | 0.00 | 0.00% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $4.2M |
| Annual profit (last year) | -$68.4M |
| Net profit margin | -1,612.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leiden, Zuid-holland |
Forecasts
